Prof. Dr. Andrew H. Miller
Emory University School of Medicine, Department of Psychiatry an Behavioral Sciences, Atlanta, USA
Identifying biomarkers and targets of the effects of inflammation on the brain to develop novel treatments for depression
Prof. Dr. Manuel Mameli
University Lausanne, Department of Fundamental Neurosciences, Lausanne, Switzerland
Research on the celluar mechanisms underlying depressive-like phenotypes in mood disorders opening avenues for potential future treatments
Prof. Diego A. Pizzagalli
Harvard Medical School, Belmont, USA
Research on neuroimaging tools reflecting dopaminergic system activity in relation to treatment in depression
Prof. Dr. Eero Castrén
University of Helsinki, Neuroscience Center, Helsinki, Finland
Research in investigating the effects of neuronal plasticity and neurotrophic factors on the adult brain and their role in the mechanismus of action of antidepressant drugs
Prof. Dr. Michael Bauer
University Hospital Carl Gustav Carus, Clinic and Polyclinic for Psychiatry and Psychotherapy, Dresden, Germany
Research in understanding pathophysiology of thyroid function in depression and bipolar disorder and the investigation of treatment algorithms in depression
l. to r.: Prof. E. Castrén, M. Bommers, Prof. M. Bauer
Prof. Dr. Ned H. Kalin
Department of Psychiatry, University of Wisconsin School of Medicine and Public Health, Madison, U.S.A.
Investigations of HPA axis regulation and amygdala function in primate animal models related to depression and anxiety.
Prof. Dr. Carmine M. Pariante
Department of Psychological Medicine, Institute of Psychiatry, Kings College London, London, Great Britain
Translational studies related to neurogenesis induced by antidepressants and response prediction
l. to r.: M. Bommers, Prof. R. Rupprecht, Prof. N. Kalin,
Prof. C. Pariante, Dr. J. Stolze
Prof. Dr. Alan F. Schatzberg
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, U.S.A.
Investigations on the role of antiglucocorticoid treatment for psychotic depression
l. to r.: Prof. R. Rupprecht, Prof. A. Schatzberg,
Prof. F. Holsboer, M. Bommers, Dr. J. Stolze
Prof. Dr. Eric J. Nestler
Mount Sinai School of Medicine
New York, NY, U.S.A.
Investigations of the molecular determinants of depression on the bases of the Social Defeat Model.
Prof. Dr. Rainer Rupprecht
93042 Regensburg, Germany
Allosteric modulation of ligand-gated ion channels as a novel principle for the treatment of depression and anxiety.
l. to r.: Dr. J. Stolze, Prof. B. Bogerts, Prof. E. Nestler,
Prof. R. Rupprecht, Prof. I. Heuser, M. Bommers
Prof. Dr. Aaron T. Beck
University of Pennsylvania
Philadelphia, PA, U.S.A.
Lifetime achievements in the defining the cognitive biases and distorted interpretations of events which represent the core psychological problem in depression and contribute to its typical symptoms, and using this knowledge to develop cognitive therapy which has helped millions of people suffering from depression.